Please login to the form below

Not currently logged in
Email:
Password:

Excellence in New Product Introductions

Sponsored by

Back to Results


Highly Commended

Octasa 1g Suppositories: Developed to Improve Patient Acceptance

by Tillotts Pharma UK


Summary of work

When Tillotts Pharma UK (TPUK) launched Octasa suppositories in April 2021, improving patient acceptance and adherence was a key objective, as many patients are reluctant to try mesalazine suppositories.
TPUK has developed a range of patient support materials to help improve patient acceptance of mesalazine suppositories and overcome any potential reluctance. The patient material has helped to improve the quality of HCP interactions with patients who are starting mesalazine suppositories.
As Octasa suppositories were launched during the COVID-19 pandemic, TPUK held a series of nine hybrid launch events for inflammatory bowel disease (IBD) nurses. The launch events were small physical events that utilised digital capabilities to link the events simultaneously. The hybrid launch events included a presentation by an IBD Clinical Psychologist who discussed the psychological aspects of using rectal therapies and tips to increase patients’ acceptance. This was followed by a live-streamed Q&A, with questions submitted virtually from all locations.

Judges' comments

This simple product launch from Tillotts Pharma was executed very well, with measurable objectives. It took a rigorous approach and had thorough market research enabling understanding of barriers to adoption. The follow-through from insight to strategy to execution and outcomes was impressive. There was a clear need and demand for this product.


Winner

Jazz Pharmaceuticals' EU Launch of Sunosi (solriamfetol) - by Jazz Pharmaceuticals
with support from GCI Health, Ashley Medical Communications, Salt and HRW


Highly commended


Finalists

ZOLGENSMA® UK Media Launch - by Novartis Gene Therapies
with support from Havas Life Medicom


Key dates

Entry deadline 26 August 2021
Extended entry deadline 2 September 2021*
*additional fee applies
Judging Day 1 October 2021
Company of the Year Interviews 22 October 2021
PMEA Event 24 November 2021